Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis

BACKGROUND: This network meta-analysis assessed the comparative risk of grade 3–5 and grade 5 treatment-related adverse events (TRAEs) for immune checkpoint inhibitors (ICIs), either alone or in combination with other modalities, for cancer treatment. METHODS: PubMed, Embase, Cochrane Library, Web o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tingting, Jin, Bo, Chen, Jun, Wang, Hui, Lin, Shuiyu, Dang, Jun, Li, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394035/
https://www.ncbi.nlm.nih.gov/pubmed/32774474
http://dx.doi.org/10.1177/1758835920940927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394035/
https://www.ncbi.nlm.nih.gov/pubmed/32774474
http://dx.doi.org/10.1177/1758835920940927

Ejemplares similares